Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-24T03:32:12.318Z Has data issue: false hasContentIssue false

Corrigendum to “Neurological soft signs significantly differentiate schizophrenia patients from healthy controls”; [Acta Neuropsychiatrica 2018;30(2):97–105]

Published online by Cambridge University Press:  09 January 2019

Konstantinos N. Fountoulakis
Affiliation:
3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Panagiotis Panagiotidis
Affiliation:
3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Xenia Gonda
Affiliation:
Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary NAP-A-SE New Antidepressant Target Research Group, Semmelweis University, Budapest, Hungary
Vasilios Kimiskidis
Affiliation:
Laboratory of Clinical Neurophysiology, School of Medicine, Aristotle University of Thessaloniki, Greece
Ioannis Nimatoudis
Affiliation:
3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
Rights & Permissions [Opens in a new window]

Abstract

Type
Corrigendum
Copyright
© Scandinavian College of Neuropsychopharmacology 2019 

Table 2 (page 100): The heading ‘Drug free (n = 98) Medicated (n = 35)’ should instead read ‘Medicated (n = 98) Drug free (n = 35)’.

The authors would like to apologise for any inconvenience caused.

References

Fountoulakis, K, Panagiotidis, P, Gonda, X, Kimiskidis, V and Nimatoudis, I. (2018) Neurological soft signs significantly differentiate schizophrenia patients from healthy controls. Acta Neuropsychiatrica 30(2), 97105. doi: 10.1017/neu.2017.29Google Scholar